To read the full story, subscribe or sign in.

Human Genome Sciences Wins Government Deal Worth $165M

June 21, 2006

The federal government agreed to pay $165 million to Human Genome Sciences Inc. under a contract to supply ABthrax (raxibacumab) to the Strategic National Stockpile. (BioWorld Today)

BioWorld

Today's news in brief

BioWorld

BioWorld briefs for Oct. 7, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Oct. 7, 2025.

ESGCT 2025: Redefining CAR T cells across cancer and autoimmunity

BioWorld Science

As the many challenges facing cell therapies are being addressed, the CAR T field continues to evolve beyond its original design of T cells engineered to target...

Chemistry Nobel’s applications could include biopharma, though translation is slow

BioWorld Science

The 2025 Nobel Prize in Chemistry “is a story full of holes, but with enormous capacity to absorb all your attention,” Heiner Linke told reporters. “And other...

Cellular senescence may trigger MS progression

BioWorld Science

Is there a link between cellular senescence and multiple sclerosis (MS) progression? Several presentations at this year’s European Committee for Treatment and...